Disclosures for "Skin Alpha-Synuclein Seed Amplification Assay for Diagnosis of Parkinson’s Disease and Other Synucleinopathies"
-
Dr. Gunzler has received research support from NIH/NINDS. Dr. Gunzler has received research support from Parkinson's Foundation. The institution of Dr. Gunzler has received research support from UCB. The institution of Dr. Gunzler has received research support from Bial.
-
Ms. Wang has nothing to disclose.
-
Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
-
Mr. Chen has nothing to disclose.
-
Dr. Elkasaby has nothing to disclose.
-
Dr. Wang has nothing to disclose.
-
Dr. Lawal has nothing to disclose.
-
Dr. Patterson has nothing to disclose.
-
Mr. Kong has nothing to disclose.